CP
MEDP icon

Canopy Partners’s Medpace MEDP Stock Holding History

Canopy Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499K Sell
943
-206
-18% -$95.1K 0.15% 125
2026
Q1 		$552K Sell
1,149
-58
-5% -$29.7K 0.19% 100
2025
Q4 		$678K Sell
1,207
-3
-0.2% -$1.7K 0.22% 87
2025
Q3 		$622K Buy
1,210
+110
+10% +$48K 0.21% 89
2025
Q2 		$345K Hold
1,100
– – 0.13% 134
2025
Q1 		$335K Buy
+1,100
New +$370K 0.13% 128

Other funds holding MEDP

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Canopy Partners's MEDP Position: Q2 2026 in Review

Canopy Partners reduced its Medpace (MEDP) stake by 18% in Q2 2026, selling an estimated $95.1K and leaving 943 shares worth $499K. The position accounts for 0.15% of the portfolio, ranked #125.

Canopy Partners first reported a position in MEDP in Q1 2025 and has held it in 6 quarters since. The position peaked at $678K in Q4 2025. 140 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Canopy Partners held 943 shares of Medpace worth $499K as of Q2 2026.
  • Canopy Partners sold 206 Medpace shares in Q2 2026, an estimated $95.1K.
  • Medpace made up 0.15% of Canopy Partners's portfolio in Q2 2026, its #125 holding.
  • Canopy Partners first reported a position in Medpace in Q1 2025 and has held it in 6 quarters since.
  • Canopy Partners's Medpace position peaked at $678K in Q4 2025.
  • 140 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Canopy Partners's 13F filing for Q2 2026, filed 22 Jul 2026.